214 related articles for article (PubMed ID: 36372519)
21. Recent advances (2015-2016) in anticancer hybrids.
Kerru N; Singh P; Koorbanally N; Raj R; Kumar V
Eur J Med Chem; 2017 Dec; 142():179-212. PubMed ID: 28760313
[TBL] [Abstract][Full Text] [Related]
22. Hybrid molecules based on 1,3,5-triazine as potential therapeutics: A focused review.
Prasher P; Sharma M; Aljabali AAA; Gupta G; Negi P; Kapoor DN; Singh I; Zacconi FC; de Jesus Andreoli Pinto T; da Silva MW; Bakshi HA; Chellappan DK; Tambuwala MM; Dua K
Drug Dev Res; 2020 Nov; 81(7):837-858. PubMed ID: 32579723
[TBL] [Abstract][Full Text] [Related]
23. Design and synthesis of mono-and di-pyrazolyl-s-triazine derivatives, their anticancer profile in human cancer cell lines, and in vivo toxicity in zebrafish embryos.
Farooq M; Sharma A; Almarhoon Z; Al-Dhfyan A; El-Faham A; Taha NA; Wadaan MAM; Torre BG; Albericio F
Bioorg Chem; 2019 Jun; 87():457-464. PubMed ID: 30927586
[TBL] [Abstract][Full Text] [Related]
24. Review of the Synthesis and Anticancer Properties of Pyrazolo[4,3-
Bernat Z; Szymanowska A; Kciuk M; Kotwica-Mojzych K; Mojzych M
Molecules; 2020 Aug; 25(17):. PubMed ID: 32872493
[TBL] [Abstract][Full Text] [Related]
25. Cinnamic acid hybrids as anticancer agents: A mini-review.
Feng LS; Cheng JB; Su WQ; Li HZ; Xiao T; Chen DA; Zhang ZL
Arch Pharm (Weinheim); 2022 Jul; 355(7):e2200052. PubMed ID: 35419808
[TBL] [Abstract][Full Text] [Related]
26. Ferrocene-containing hybrids as potential anticancer agents: Current developments, mechanisms of action and structure-activity relationships.
Wang R; Chen H; Yan W; Zheng M; Zhang T; Zhang Y
Eur J Med Chem; 2020 Mar; 190():112109. PubMed ID: 32032851
[TBL] [Abstract][Full Text] [Related]
27. Current status of carbazole hybrids as anticancer agents.
Wang G; Sun S; Guo H
Eur J Med Chem; 2022 Feb; 229():113999. PubMed ID: 34838335
[TBL] [Abstract][Full Text] [Related]
28. The In Vitro Anticancer Activity and Potential Mechanism of Action of 1-[(1R,2S)-2-fluorocyclopropyl]Ciprofloxacin-(4-methyl/phenyl/benzyl-3- aryl)-1,2,4-triazole-5(4H)-thione Hybrids.
Zhang YZ; Liu HL; He QS; Xu Z
Curr Top Med Chem; 2020; 20(16):1493-1498. PubMed ID: 32156237
[TBL] [Abstract][Full Text] [Related]
29. Recent Development of Sulfonyl or Sulfonamide Hybrids as Potential Anticancer Agents: A Key Review.
Rakesh KP; Wang SM; Leng J; Ravindar L; Asiri AM; Marwani HM; Qin HL
Anticancer Agents Med Chem; 2018; 18(4):488-505. PubMed ID: 29110622
[TBL] [Abstract][Full Text] [Related]
30. Recent updates on 1,2,3-triazole-containing hybrids with in vivo therapeutic potential against cancers: A mini-review.
Zhao S; Liu J; Lv Z; Zhang G; Xu Z
Eur J Med Chem; 2023 May; 251():115254. PubMed ID: 36893627
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and antiproliferative activity evaluation of a series of pyrrolo[2,1-f][1,2,4]triazine derivatives.
Xiang HY; Chen YH; Wang Y; Zhang X; Ding J; Meng LH; Yang CH
Bioorg Med Chem Lett; 2020 Jun; 30(12):127194. PubMed ID: 32317209
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and in vitro anticancer evaluation of some 4,6-diamino-1,3,5-triazine-2-carbohydrazides as Rad6 ubiquitin conjugating enzyme inhibitors.
Kothayer H; Spencer SM; Tripathi K; Westwell AD; Palle K
Bioorg Med Chem Lett; 2016 Apr; 26(8):2030-4. PubMed ID: 26965855
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, Structure and Antiproliferative Activity of New pyrazolo[4,3- e]triazolo[4,5-b][1,2,4]triazine Derivatives.
Mojzych M; Tarasiuk P; Karczmarzyk Z; Juszczak M; Rzeski W; Fruzinski A; Wozny A
Med Chem; 2018; 14(1):53-59. PubMed ID: 29065838
[TBL] [Abstract][Full Text] [Related]
34. Current development of pyrazole-azole hybrids with anticancer potential.
Zhang S; Ye Y; Zhang Q; Luo Y; Wang ZC; Wu YZ; Zhang XP; Yi C
Future Med Chem; 2023 Aug; 15(16):1527-1548. PubMed ID: 37610862
[TBL] [Abstract][Full Text] [Related]
35. Anticancer activities, structure-activity relationship, and mechanism of action of 12-, 14-, and 16-membered macrolactones.
Wang R
Arch Pharm (Weinheim); 2021 Sep; 354(9):e2100025. PubMed ID: 34138486
[TBL] [Abstract][Full Text] [Related]
36. Anticancer potential of cardiac glycosides and steroid-azole hybrids.
Hou Y; Shang C; Meng T; Lou W
Steroids; 2021 Jul; 171():108852. PubMed ID: 33887267
[TBL] [Abstract][Full Text] [Related]
37. An overview on the recent developments of 1,2,4-triazine derivatives as anticancer compounds.
Cascioferro S; Parrino B; Spanò V; Carbone A; Montalbano A; Barraja P; Diana P; Cirrincione G
Eur J Med Chem; 2017 Dec; 142():328-375. PubMed ID: 28851503
[TBL] [Abstract][Full Text] [Related]
38. Exploration of novel heterofused 1,2,4-triazine derivative in colorectal cancer.
Hermanowicz JM; Szymanowska A; Sieklucka B; Czarnomysy R; Pawlak K; Bielawska A; Bielawski K; Kalafut J; Przybyszewska A; Surazynski A; Rivero-Muller A; Mojzych M; Pawlak D
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):535-548. PubMed ID: 33522320
[TBL] [Abstract][Full Text] [Related]
39. Current Scenario of Acridine Hybrids with Anticancer Potential.
Zhang Q; Yu X
Curr Top Med Chem; 2021; 21(19):1773-1786. PubMed ID: 34348622
[TBL] [Abstract][Full Text] [Related]
40. Di- and tri-substituted s-triazine derivatives: Synthesis, characterization, anticancer activity in human breast-cancer cell lines, and developmental toxicity in zebrafish embryos.
El-Faham A; Farooq M; Almarhoon Z; Alhameed RA; Wadaan MAM; de la Torre BG; Albericio F
Bioorg Chem; 2020 Jan; 94():103397. PubMed ID: 31706684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
